GLP-2 TRZ 60 mg – Research-Grade Dual-Agonist Peptide

Unleash the potential of advanced metabolic research with GLP-2 TRZ 60 mg, a premium-quality peptide designed specifically for in-vitro and laboratory-based investigation. Engineered as a high-purity dual-receptor agonist analog (targeting both GLP-1 and GIP receptor pathways), this compound supports exploration of complex metabolic, appetite and body-composition signalling mechanisms.

Why Choose GLP-2 TRZ for Your Research?

• Dual-agonist mechanism: GLP-2 analogues are increasingly recognised for their role in glucose homeostasis, insulin sensitivity and nutrient signalling. PubMed
• High-purity formulation: Each batch is verified by HPLC/analytical methods to meet purity benchmarks (≥ 99 %) helping ensure reproducibility and reliability in cell-based or assay-driven workflows. myoasislabs.com
• Optimised for metabolic studies: Whether your project is focused on satiety regulation, adiposity/fat-metabolism, or dual receptor pathway kinetics (GLP-1 + GIP), GLP-2 TRZ provides the research grade specificity you need. receptorforge.com+1
• Global research use: Offered to qualified laboratories across the United States, United Kingdom, Germany, United Arab Emirates, Australia, Canada, China, France, Saudi Arabia, Switzerland and beyond.

H2: Key Specifications & Handling Notes

• Format: Lyophilized powder (60 mg vial) – supplied under strict research-use only terms.

• Purity: Verified ≥ 99 % by HPLC. Peptideco+1

• Storage: Store lyophilized at –20 °C (or 2-8 °C short-term); once re-constituted, maintain at 2-8 °C, protect from light and use promptly. Mindful Research

• Intended Use: Strictly for in-vitro/in-lab research. Not for human or veterinary use, not approved for therapeutic or clinical applications.

• Handling: Use appropriate PPE and lab protocols. Follow institutional safety and regulatory guidelines.

H4: Research Applications & Use Cases

• Exploration of dual incretin receptor agonism (GLP-1 + GIP) and downstream metabolic pathways.

• Studies of appetite regulation, nutrient intake, satiety signalling and energy-balance.

• Investigations into glucose metabolism, insulin sensitivity, adiposity and fat-metabolism in controlled laboratory models.

• Body-composition and metabolic-health research in global cohorts (cells, tissue, in-vitro platforms).

• Comparative signalling research leveraging the unique properties of dual-agonist peptides versus single-pathway analogues.

H4: Important Regulatory and Use Disclaimer

This product is supplied for research purposes only and is not intended for human consumption, clinical or diagnostic use. Statements regarding potential metabolic or therapeutic effects are for educational and research-context only and have not been evaluated by any health authority in any jurisdiction. Researchers must ensure compliance with all local laws, institutional protocols and ethical guidelines prior to use.

H2: Global Access & Support

We serve qualified research institutions and laboratories across the US, UK, Germany, UAE, Australia, Canada, China, France, Saudi Arabia and Switzerland, offering same-day shipping (where permitted) and comprehensive documentation including Certificate of Analysis (COA). Dedicated support is available to assist with shipping logistics, documentation and storage guidance.